134 related articles for article (PubMed ID: 17083655)
1. Impact and risk factors for early-onset group B streptococcal morbidity: analysis of a national, population-based cohort in Sweden 1997-2001.
Håkansson S; Källén K
BJOG; 2006 Dec; 113(12):1452-8. PubMed ID: 17083655
[TBL] [Abstract][Full Text] [Related]
2. Early-onset group B streptococcal disease in the era of maternal screening.
Puopolo KM; Madoff LC; Eichenwald EC
Pediatrics; 2005 May; 115(5):1240-6. PubMed ID: 15867030
[TBL] [Abstract][Full Text] [Related]
3. Prevention of early-onset Group B Streptococcal disease - the Northern Ireland experience.
Eastwood KA; Craig S; Sidhu H; Boyle M; Gannon C; Ong G; Lupari M; Craven A; Magowan S; Ashe RG
BJOG; 2015 Feb; 122(3):361-7. PubMed ID: 24861487
[TBL] [Abstract][Full Text] [Related]
4. Reduced incidence of neonatal early-onset group B streptococcal infection after promulgation of guidelines for risk-based intrapartum antibiotic prophylaxis in Sweden: analysis of a national population-based cohort.
Håkansson S; Lilja M; Jacobsson B; Källén K
Acta Obstet Gynecol Scand; 2017 Dec; 96(12):1475-1483. PubMed ID: 28832916
[TBL] [Abstract][Full Text] [Related]
5. Maternal group B streptococcus infection, neonatal outcome and the role of preventive strategies.
Elvedi-Gasparović V; Peter B
Coll Antropol; 2008 Mar; 32(1):147-51. PubMed ID: 18494200
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a strategy to prevent neonatal early-onset group B streptococcal (GBS) sepsis.
Renner RM; Renner A; Schmid S; Hoesli I; Nars P; Holzgreve W; Surbek DV
J Perinat Med; 2006; 34(1):32-8. PubMed ID: 16489884
[TBL] [Abstract][Full Text] [Related]
7. Continued early onset group B streptococcal infections in the era of intrapartum prophylaxis.
Pulver LS; Hopfenbeck MM; Young PC; Stoddard GJ; Korgenski K; Daly J; Byington CL
J Perinatol; 2009 Jan; 29(1):20-5. PubMed ID: 18704032
[TBL] [Abstract][Full Text] [Related]
8. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: experience in the United States and implications for a potential group B streptococcal vaccine.
Schrag SJ; Verani JR
Vaccine; 2013 Aug; 31 Suppl 4():D20-6. PubMed ID: 23219695
[TBL] [Abstract][Full Text] [Related]
9. The effect of universal maternal screening on the incidence of neonatal early-onset group B streptococcal disease.
Eberly MD; Rajnik M
Clin Pediatr (Phila); 2009 May; 48(4):369-75. PubMed ID: 18832528
[TBL] [Abstract][Full Text] [Related]
10. Preventing neonatal group B streptococcal infection. Intrapartum antibiotic prophylaxis in some high-risk situations.
Prescrire Int; 2011 Mar; 20(114):72-7. PubMed ID: 21648230
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for early-onset group B streptococcal sepsis: estimation of odds ratios by critical literature review.
Benitz WE; Gould JB; Druzin ML
Pediatrics; 1999 Jun; 103(6):e77. PubMed ID: 10353974
[TBL] [Abstract][Full Text] [Related]
12. Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: residual problems.
Pinto NM; Soskolne EI; Pearlman MD; Faix RG
J Perinatol; 2003 Jun; 23(4):265-71. PubMed ID: 12774131
[TBL] [Abstract][Full Text] [Related]
13. Group B streptococcal carriage in Sweden: a national study on risk factors for mother and infant colonisation.
Håkansson S; Axemo P; Bremme K; Bryngelsson AL; Wallin MC; Ekström CM; Granlund M; Jacobsson B; Källén K; Spetz E; Tessin I;
Acta Obstet Gynecol Scand; 2008; 87(1):50-8. PubMed ID: 18158627
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of universal antenatal screening for group B streptococcus.
Van Dyke MK; Phares CR; Lynfield R; Thomas AR; Arnold KE; Craig AS; Mohle-Boetani J; Gershman K; Schaffner W; Petit S; Zansky SM; Morin CA; Spina NL; Wymore K; Harrison LH; Shutt KA; Bareta J; Bulens SN; Zell ER; Schuchat A; Schrag SJ
N Engl J Med; 2009 Jun; 360(25):2626-36. PubMed ID: 19535801
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of early-onset neonatal group B streptococcal infection: implications for screening.
Konrad G; Katz A
Can Fam Physician; 2007 Jun; 53(6):1055, 2001:e.1-6, 1054. PubMed ID: 17872785
[TBL] [Abstract][Full Text] [Related]
16. Modelling the effect of the introduction of antenatal screening for group B
Bevan D; White A; Marshall J; Peckham C
BMJ Open; 2019 Mar; 9(3):e024324. PubMed ID: 30904850
[TBL] [Abstract][Full Text] [Related]
17. Outcome of a screening program for the prevention of neonatal early-onset group B Streptococcus infection: a population-based cohort study in Inner Mongolia, China.
Ji Y; Zhao C; Ma XX; Peppelenbosch MP; Ma Z; Pan Q
J Med Microbiol; 2019 May; 68(5):803-811. PubMed ID: 30994439
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of maternal and neonatal chemoprophylaxis for early-onset group B streptococcal disease.
Stafford IA; Stewart RD; Sheffield JS; Wendel GD; Sanchez PJ; McIntire DD; Roberts SW
Obstet Gynecol; 2012 Jul; 120(1):123-9. PubMed ID: 22914400
[TBL] [Abstract][Full Text] [Related]
19. Ten-year study on the effect of intrapartum antibiotic prophylaxis on early onset group B streptococcal and Escherichia coli neonatal sepsis in Australasia.
Daley AJ; Isaacs D;
Pediatr Infect Dis J; 2004 Jul; 23(7):630-4. PubMed ID: 15247601
[TBL] [Abstract][Full Text] [Related]
20. Early onset neonatal group B streptococcal sepsis.
Oh W
Am J Perinatol; 2013 Feb; 30(2):143-7. PubMed ID: 23322392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
